Clinical Trial Update: PET/CT for Trop2 ADC Response Evaluation NSCLC

View source ↗

Summary

A clinical trial is recruiting to evaluate a Trop2-targeting antibody-drug conjugate for assessing treatment response in non-small cell lung cancer using PET/CT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Trop2 ADC

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: NSCLC, Trop2 | Status: RECRUITING